医学
恶性胸腔积液
肺癌
恶性肿瘤
胸腔积液
癌症
疾病
肿瘤科
阶段(地层学)
内科学
肺
肺癌的治疗
生物
古生物学
作者
Claire Tissot,Pierre Gay,C. Brun,Μarios E. Froudarakis
摘要
Abstract Lung cancer is the most common fatal malignancy worldwide. Approximately 75% of non‐small‐cell lung cancer (NSCLC) patients are diagnosed at an advanced or a metastatic stage. Since 2007, NSCLC patients with malignant pleural effusion (MPE) are staged as M1 disease. During the last decades, chemotherapeutic agents failed to offer a significant improvement of survival in patients with metastatic disease. The current review aims to summarize the actual situation of the recently developed therapies in patients with lung cancer and MPE.
科研通智能强力驱动
Strongly Powered by AbleSci AI